from Dr Joseph Mercola
Story at-a-glance
- The antiviral drug remdesivir, brand name Veklury, is approved for use against covid-19 despite research showing it lacks effectiveness and can cause high rates of organ failure
- John Beaudoin is calling for a criminal investigation into remdesivir, citing data that it may have killed 100,000 people in the U.S.
- Beaudoin received all the death certificates in Massachusetts from 2015 to 2022, finding 1,840 excess deaths from acute renal failure from January 1, 2021, to November 30, 2022, which he believes may be due to remdesivir
- A study published in The Lancet found “no clinical benefit” from the use of remdesivir in hospitalized patients
- The U.S. government pays hospitals a 20% upcharge on the entire hospital bill when remdesivir is used
The U.S. Food and Drug Administration authorized the experimental antiviral drug remdesivir, brand name Veklury, for emergency use against covid-19 in May 2020.1 By October 2020, it had received full approval.2 It remains a primary treatment for covid-19 in hospitals, despite research showing it lacks effectiveness3 and can cause high rates of organ failure.4
Pingback: Criminal investigation for excess deaths due to Remdesivir called for — Waikanae Watch – New Human New Earth Communities
“The U.S. government pays hospitals a 20% upcharge on the entire hospital bill when remdesivir is used”
What possible explanation can there be for this?
As Ronald Regan said: The world’s second oldest profession – politician – bears a close resemblance to the oldest.